This statistic displays a projection of the top 10 global orphan drugs based on revenues in 2024. For that year, it is projected that Roche's and AbbVie's Venclexta will generate some 2.9 billion U.S. dollars in revenue. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*
* Products that have orphan and non-orphan drug
designations and are expected to generate less than 50% of their sales in 2018 and 2024 from
their orphan-designated indication/s, are excluded from this statistic. This has led to the exclusion
of therapies such as Avastin, Opdivo, Enbrel, Herceptin, Humira and Remicade.
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
Your perfect start with Statista
Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references
$59$39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract; Prices do not include sales tax.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Evaluate. (April 25, 2019). Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)* [Graph]. In Statista. Retrieved June 01, 2020, from https://www.statista.com/statistics/373382/projection-of-top-10-oprhan-drugs-based-on-global-revenue-2020/
Evaluate. "Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*." Chart. April 25, 2019. Statista. Accessed June 01, 2020. https://www.statista.com/statistics/373382/projection-of-top-10-oprhan-drugs-based-on-global-revenue-2020/
Evaluate. (2019). Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: June 01, 2020. https://www.statista.com/statistics/373382/projection-of-top-10-oprhan-drugs-based-on-global-revenue-2020/
Evaluate. "Projected Top 10 Orphan Drugs Worldwide by Revenue in 2024 (in Billion U.S. Dollars)*." Statista, Statista Inc., 25 Apr 2019, https://www.statista.com/statistics/373382/projection-of-top-10-oprhan-drugs-based-on-global-revenue-2020/
Evaluate, Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/373382/projection-of-top-10-oprhan-drugs-based-on-global-revenue-2020/ (last visited June 01, 2020)
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
